Expression of Foxp3 was positive in 87.5% (14/16) cases that had lymph node metastasis, and the positive rate was significantly higher than the samples with the absence of lymph node metastasis (55.9%, 19/34). The gene discussed is FOXP3; the disease is metastatic malignant neoplasm in the lymph nodes.